Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,187
datasets available to search
ShareScore release 0.7.1
Dataset results
8,187 results for “Lung cancer”
Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04712903. IPD Sharing: YES. Countries: 1. Publications: 1.
Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00402051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
ClinicalTrials.gov study NCT00711594. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04475939. IPD Sharing: YES. Countries: 27. Publications: 1.
Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02659059. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01625234. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00600015. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer
ClinicalTrials.gov study NCT02789345. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00653939. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
ClinicalTrials.gov study NCT02240238. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
ClinicalTrials.gov study NCT00398138. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04075396. IPD Sharing: YES. Countries: 3. Publications: 1.
Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk
ClinicalTrials.gov study NCT07347977. IPD Sharing: NO. Countries: 1. Publications: 12.
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
ClinicalTrials.gov study NCT02087176. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable
ClinicalTrials.gov study NCT03191786. IPD Sharing: Not stated. Countries: 24. Publications: 4.
Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR
ClinicalTrials.gov study NCT00446225. IPD Sharing: NO. Countries: 3. Publications: 4.
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT01244191. IPD Sharing: NO. Countries: 23. Publications: 2.
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
ClinicalTrials.gov study NCT01642004. IPD Sharing: Not stated. Countries: 21. Publications: 7.
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations
ClinicalTrials.gov study NCT01532089. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
ClinicalTrials.gov study NCT02402920. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.